Healthcare US Internet of Medical Things (IoMT) and Remote Patient Monitoring Growth Opportunities

Growth Strategies to Boost Health Data Quality and Value

INDUSTRY
Healthcare

RELEASE DATE
06-May-2022
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K763-01-00-00-00
SKU
HC03538-NA-MT_26515
Yes
SHARE

US Internet of Medical Things (IoMT) and Remote Patient Monitoring Growth Opportunities
Published on: 06-May-2022 | SKU: HC03538-NA-MT_26515

Need more details?
$2,450.00
DownloadLink
Need more details?

Frost & Sullivan has recognized remote patient monitoring as one of the top 5 trends in digital health investments. This report addresses how the Internet of Medical Things (IoMT) market offers significant growth opportunities in remote patient monitoring for all healthcare stakeholders and leading information and communication technology (ICT) companies. The volume of data available from remote patient monitoring devices will continue to increase as the convergence of IoMT, 5G, and WiFi 6 creates the infrastructure needed to support it. With the exponential increase in the data flow, there will be a need to prioritize data quality and enhance data security and privacy.

The report focuses exclusively on the IoMT market in the United States. It segments the market according to its industry participants, which are as follows: medical device companies, electronic health records (EHR) or electronic medical record (EMR) companies, healthcare providers, payers, pharmaceutical companies, telehealth & virtual healthcare companies, and private & equity firms. The report identifies the current strengths of ICT companies that can help them enter the digital healthcare market. The drivers, restraints, and growth opportunities for this market have also been provided.

Author: Victor Camlek

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives Emerging from the IoMT Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Definitions

The IoMT Model for RPM

Market Segmentation by Industry Participants

How does SDoH Impact Patient Health?

Why does SDoH Matter in RPM?

Towards a Patient-centric Model

Growth Drivers

Growth Drivers Analysis

Growth Drivers Analysis (continued)

Growth Restraints

Growth Restraints Analysis

Growth Restraints Analysis (continued)

Growth Opportunity 1: Enhancement of Patient Health Data Value while Guaranteeing Compliance

Growth Opportunity 1: Enhancement of Patient Health Data Value while Guaranteeing Compliance (continued)

Growth Opportunity 2: Integration of SDoH and PGHD for Better Patient Outcomes

Growth Opportunity 2: Integration of SDoH and PGHD for Better Patient Outcomes (continued)

Growth Opportunity 3: Health Information Exchange Solutions for Data Interoperability

Growth Opportunity 3: Health Information Exchange Solutions for Data Interoperability (continued)

Growth Opportunity 4: Big ICT Companies’ Potential Expansion into IoMT and RPM

Growth Opportunity 4: Big ICT Companies’ Potential Expansion into IoMT and RPM (continued)

List of Exhibits

Legal Disclaimer

List of Figures
  • IoMT for RPM: Growth Drivers, United States, 2022–2027
  • IoMT for RPM: Growth Restraints, United States, 2022–2027

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

15 Sep 2026   |   Global   |   Market Research

Vendor Profiles: Advanced Wound Care Management Market, Global, 2025

The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...

11 Sep 2026   |   Global   |   Frost Radar

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026

Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Frost & Sullivan has recognized remote patient monitoring as one of the top 5 trends in digital health investments. This report addresses how the Internet of Medical Things (IoMT) market offers significant growth opportunities in remote patient monitoring for all healthcare stakeholders and leading information and communication technology (ICT) companies. The volume of data available from remote patient monitoring devices will continue to increase as the convergence of IoMT, 5G, and WiFi 6 creates the infrastructure needed to support it. With the exponential increase in the data flow, there will be a need to prioritize data quality and enhance data security and privacy. The report focuses exclusively on the IoMT market in the United States. It segments the market according to its industry participants, which are as follows: medical device companies, electronic health records (EHR) or electronic medical record (EMR) companies, healthcare providers, payers, pharmaceutical companies, telehealth & virtual healthcare companies, and private & equity firms. The report identifies the current strengths of ICT companies that can help them enter the digital healthcare market. The drivers, restraints, and growth opportunities for this market have also been provided. Author: Victor Camlek
More Information
Deliverable Type Market Research
Author Victor Camlek
Industries Healthcare
No Index No
Is Prebook No
List of Charts and Figures IoMT for RPM: Growth Drivers, United States, 2022–2027~ IoMT for RPM: Growth Restraints, United States, 2022–2027~
Podcast No
WIP Number K763-01-00-00-00

US Internet of Medical Things (IoMT) and Remote Patient Monitoring Growth Opportunities

$2,450.00
In stock
SKU
HC03538-NA-MT_26515